EUCTR2020-001685-11-FR进行中（未招募）1 期
RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine - REPAIR-GETUG P16
INSTITUT DE CANCEROLOGIE DE L'OUEST0 个研究点目标入组 44 人开始时间: 2020年5月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 14
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by MetforminProstate CancerNCT04536805Institut Cancerologie de l'Ouest44
招募中
3 期
Prostate bed irradiation with alternative radio-oncological approachesDRKS00015231niversitätsklinikum HeidelbergAbteilung RadioOnkologie und Strahlentherapie897
招募中
2 期
EREctile Conservation after prostate radiation Therapy (ERECT); a prospective phase 2 trialProstate cancerNL-OMON50019niversitair Medisch Centrum Utrecht70
已完成
2 期
Brachytherapy for Recurrent Prostate CancerRecurrent Prostate CancerBrachytherapy RemedialNCT01956058Centre Georges Francois Leclerc30
招募中
2 期
Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II trial2024-513207-13-00Institut De Cancerologie De L Ouest96